Optimizing antibiotic prescribing : collective approaches to managing a common-pool resource
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved..
BACKGROUND: Antimicrobial resistance (AMR) is one of the greatest threats in 21st century medicine. AMR has been characterized as a social dilemma. A familiar version describes the situation in which a collective resource (in this case, antibiotic efficacy) is exhausted due to over-exploitation. The dilemma arises because individuals are motivated to maximize individual payoffs, although the collective outcome is worse if all act in this way.
OBJECTIVES: We aim to outline the implications for antimicrobial stewardship of characterizing antibiotic overuse as a social dilemma.
SOURCES: We conducted a narrative review of the literature on interventions to promote the conservation of resources in social dilemmas.
CONTENT: The social dilemma of antibiotic over-use is complicated by the lack of visibility and imminence of AMR, a loose coupling between individual actions and the outcome of AMR, and the agency relationships inherent in the prescriber role. We identify seven strategies for shifting prescriber behaviour and promoting a focus on the collectively desirable outcome of conservation of antibiotic efficacy: (1) establish clearly defined boundaries and access rights; (2) raise the visibility and imminence of the problem; (3) enable collective choice arrangements; (4) conduct behaviour-based monitoring; (5) use social and reputational incentives and sanctions; (6) address misalignment of goals and incentives; and (7) provide conflict resolution mechanisms.
IMPLICATIONS: We conclude that this theoretic analysis of antibiotic stewardship could make the problem of optimizing antibiotic prescribing more tractable, providing a theory base for intervention development.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases - 25(2019), 11 vom: 23. Nov., Seite 1356-1363 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tarrant, C [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-Infective Agents |
---|
Anmerkungen: |
Date Completed 04.02.2020 Date Revised 04.02.2020 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.cmi.2019.03.008 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM295331518 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM295331518 | ||
003 | DE-627 | ||
005 | 20231225083429.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.cmi.2019.03.008 |2 doi | |
028 | 5 | 2 | |a pubmed24n0984.xml |
035 | |a (DE-627)NLM295331518 | ||
035 | |a (NLM)30910716 | ||
035 | |a (PII)S1198-743X(19)30110-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tarrant, C |e verfasserin |4 aut | |
245 | 1 | 0 | |a Optimizing antibiotic prescribing |b collective approaches to managing a common-pool resource |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.02.2020 | ||
500 | |a Date Revised 04.02.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved. | ||
520 | |a BACKGROUND: Antimicrobial resistance (AMR) is one of the greatest threats in 21st century medicine. AMR has been characterized as a social dilemma. A familiar version describes the situation in which a collective resource (in this case, antibiotic efficacy) is exhausted due to over-exploitation. The dilemma arises because individuals are motivated to maximize individual payoffs, although the collective outcome is worse if all act in this way | ||
520 | |a OBJECTIVES: We aim to outline the implications for antimicrobial stewardship of characterizing antibiotic overuse as a social dilemma | ||
520 | |a SOURCES: We conducted a narrative review of the literature on interventions to promote the conservation of resources in social dilemmas | ||
520 | |a CONTENT: The social dilemma of antibiotic over-use is complicated by the lack of visibility and imminence of AMR, a loose coupling between individual actions and the outcome of AMR, and the agency relationships inherent in the prescriber role. We identify seven strategies for shifting prescriber behaviour and promoting a focus on the collectively desirable outcome of conservation of antibiotic efficacy: (1) establish clearly defined boundaries and access rights; (2) raise the visibility and imminence of the problem; (3) enable collective choice arrangements; (4) conduct behaviour-based monitoring; (5) use social and reputational incentives and sanctions; (6) address misalignment of goals and incentives; and (7) provide conflict resolution mechanisms | ||
520 | |a IMPLICATIONS: We conclude that this theoretic analysis of antibiotic stewardship could make the problem of optimizing antibiotic prescribing more tractable, providing a theory base for intervention development | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Antimicrobial stewardship | |
650 | 4 | |a Bacterial | |
650 | 4 | |a Choice behaviour | |
650 | 4 | |a Drug resistance | |
650 | 4 | |a Health resources | |
650 | 4 | |a Humans | |
650 | 4 | |a Prescribing | |
650 | 4 | |a Social dilemma | |
650 | 7 | |a Anti-Infective Agents |2 NLM | |
700 | 1 | |a Colman, A M |e verfasserin |4 aut | |
700 | 1 | |a Chattoe-Brown, E |e verfasserin |4 aut | |
700 | 1 | |a Jenkins, D R |e verfasserin |4 aut | |
700 | 1 | |a Mehtar, S |e verfasserin |4 aut | |
700 | 1 | |a Perera, N |e verfasserin |4 aut | |
700 | 1 | |a Krockow, E M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases |d 1995 |g 25(2019), 11 vom: 23. Nov., Seite 1356-1363 |w (DE-627)NLM094580014 |x 1469-0691 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2019 |g number:11 |g day:23 |g month:11 |g pages:1356-1363 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cmi.2019.03.008 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 25 |j 2019 |e 11 |b 23 |c 11 |h 1356-1363 |